PubRank
Search
About
Alan Korman
Author PubWeight™ 22.58
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.
Proc Natl Acad Sci U S A
2003
5.49
2
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.
Proc Natl Acad Sci U S A
2008
4.43
3
Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Clin Cancer Res
2009
2.97
4
Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy.
Semin Oncol
2010
2.51
5
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.
Int Immunol
2009
2.10
6
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
J Immunol
2008
1.79
7
Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques.
J Immunol
2003
1.54
8
Enhanced protein production by engineered zinc finger proteins.
Biotechnol Bioeng
2007
1.26
9
PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.
Cancer Res
2011
1.24